The U.S. Food and Drug Administration (FDA) issued a recall Oct. 24 for prazosin hydrochloride, a popular medication for treating high blood pressure, over concerns of cancer-causing impurities.

Nearly 590,000 bottles of blood pressure drugs have been recalled over concerns that they may contain a potentially ...

Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...

More than half a million bottles of prazosin hydrochloride, a common blood pressure medication, have been recalled by Teva Pharmaceuticals after tests found traces of a possible cancer-causing ...

The Federal Drug Administration said drugmakers have recalled more than 580,000 bottles of a blood pressure medication over ...

A pharmaceutical company has issued a voluntary recall for more than a half-million bottles of blood pressure medication after tests showed the capsules had high levels of potentially cancer-causing ...

The Food and Drug Administration issued an alert affecting more than 580,800 bottles of Prazosin Hydrochloride capsules distributed by Teva Pharmaceuticals.

More than half a million bottles of the blood pressure medication Prazosin Hydrochloride distributed by Teva Pharmaceuticals have been recalled. The recall is due to the test results of the capsules ...